Text size
this story is by
Meir Heth
I assume that Teva Pharmaceutical Industries' shareholders were surprised to learn, in the report sent them before a general assembly, that they were being asked to approve bloated, excessive pay packages for the company's board members. The proposal, which had been approved by the company's relevant organs, is to pay them $190,000 a year plus $2,000 for each board meeting they attend in Israel, and...
